A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/12085249

Br. J. Cancer 2002 Jul 1 87 1 15-20

Download in:

View as

Triples

General Info

PMID
12085249